Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Docetaxel loaded mPEG-PLA nanoparticles for sarcoma therapy: preparation, characterization, pharmacokinetics, and anti-tumor efficacy
Jianhua Chen, Eerdunbagena Ning, Zhijun Wang, et al.
Drug Delivery (2021) Vol. 28, Iss. 1, pp. 1389-1396
Open Access | Times Cited: 20

Showing 20 citing articles:

Superparamagnetic Iron Oxide Nanoparticles: Cytotoxicity, Metabolism, and Cellular Behavior in Biomedicine Applications
Hao Wei, Yangnan Hu, Junguo Wang, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 6097-6113
Open Access | Times Cited: 97
Doxorubicin-loaded micelles in tumor cell-specific chemotherapy
Yasir Qasim Almajidi, Mustafa M. Kadhim, Fahad Alsaikhan, et al.
Environmental Research (2023) Vol. 227, pp. 115722-115722
Closed Access | Times Cited: 39
CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination
Yunshu Zhu, Leilei Liang, Yuxi Zhao, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges
Yingjie Jiang, Chunmei Yan, Minghao Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 135072-135072
Closed Access | Times Cited: 11
Recent advances in the targeted delivery of paclitaxel nanomedicine for cancer therapy
Faisal Raza, Hajra Zafar, Muhammad Wasim Khan, et al.
Materials Advances (2021) Vol. 3, Iss. 5, pp. 2268-2290
Open Access | Times Cited: 43
Arenobufagin-loaded PEG-PLA nanoparticles for reducing toxicity and enhancing cancer therapy
Jia-Ying Yang, Bo Sun, Xiaolu Wei, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 21
Enhanced postoperative cancer therapy by iron-based hydrogels
Haomeng Zhang, Meng Zhang, Xinyu Zhang, et al.
Biomaterials Research (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 26
The emerging role of cancer nanotechnology in the panorama of sarcoma
Laura Mercatali, Silvia Vanni, Giacomo Miserocchi, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 23
Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer
Jing Wang, Yan Zhang, GuangPeng Zhang, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 588-599
Open Access | Times Cited: 19
Biodegradable polyester-based nano drug delivery system in cancer chemotherapy: a review of recent progress (2021–2023)
Zongheng Wang, Miaomiao Xiao, Fangliang Guo, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 13
New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
Gyuhee Seong, Sandra P. D’Angelo
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Evaluation of cardiotoxicity of anthracycline‐containing chemotherapy regimens in patients with bone and soft tissue sarcomas: A study of the FDA adverse event reporting system joint single‐center real‐world experience
Zeming Mo, Yaotiao Deng, Yiwen Bao, et al.
Cancer Medicine (2023) Vol. 12, Iss. 24, pp. 21709-21724
Open Access | Times Cited: 7
In vivo safety evaluation method for nanomaterials for cancer therapy
Mengqi Chen, Jingyi Hei, Yan Huang, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 9, pp. 2126-2141
Closed Access | Times Cited: 2
CHEMOTHERAPY, IMMUNOTHERAPY, AND TARGETED THERAPY FOR OSTEOSARCOMA: RECENT ADVANCEMENTS
Esther Ekpe Adewuyi, Harshal Chorya, Muili Abdulbasit, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104575-104575
Closed Access | Times Cited: 2
Advancements in Nanoengineered Paclitaxel Formulations: A Comprehensive Review of Blood-Brain Barrier Infiltration Strategies for Glioblastoma Therapy
Stabak Das, Prithviraj Chakraborty, Debarupa Dutta Chakraborty, et al.
Biomedical Engineering Advances (2024) Vol. 7, pp. 100122-100122
Open Access | Times Cited: 1
PD-L1 antibody conjugated dihydrotanshinone I-loaded polymeric nanoparticle for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death
Xue Wang, Ziqi Jing, Xiaobin Huang, et al.
International Journal of Pharmaceutics (2024), pp. 125004-125004
Closed Access | Times Cited: 1
Docetaxel-Loaded Methoxy poly(ethylene glycol)-poly (L-lactic Acid) Nanoparticles for Breast Cancer: Synthesis, Characterization, Method Validation, and Cytotoxicity
Shumaila Miraj, Hamid Saeed, Mehwish Iqtedar, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1600-1600
Open Access | Times Cited: 2
Tyrosine kinase inhibitor-loaded biomimetic nanoparticles as a treatment for osteosarcoma
Federica Giordano, Stefania Lenna, Gherardo Baudo, et al.
Cancer Nanotechnology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Pharmacokinetics of IONPs
Mohammad-Nabil Savari, Ali Jabali
Nanomedicine and nanotoxicology (2023), pp. 67-113
Closed Access | Times Cited: 1
PD-L1 Antibody Conjugated Dihydrotanshinone I-loaded Polymeric Nanoparticle for Targeted Cancer Immunotherapy Combining PD-L1 Blockade with Immunogenic Cell Death
Handong Wang, Ziqi Jing, Tianyue Yan, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top